Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pgp Inhibition and Ondansetron CNS Biodistribution
NCT03809234Phase 1Terminated
- Sponsor
- Washington University School of Medicine
- Start
- May 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of tariquidar in neuropathic pain, sponsored by Washington University School of Medicine. Started May 2019; status: terminated.
02
Drugs
tariquidar
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT03809234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03809234.